Topics

Sobi to purchase Dova Pharmaceuticals in $915m deal

04:33 EDT 1 Oct 2019 | Pharmaceutical Technology

Swedish Orphan Biovitrum AB (Sobi) has agreed to acquire US-based Dova Pharmaceuticals in a transaction valued up to $915m. Dova...
Read More...

The post Sobi to purchase Dova Pharmaceuticals in $915m deal appeared first on Pharmaceutical Technology.

Original Article: Sobi to purchase Dova Pharmaceuticals in $915m deal

NEXT ARTICLE

More From BioPortfolio on "Sobi to purchase Dova Pharmaceuticals in $915m deal"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...